Shree Ganesh Remedies Submits Q4FY26 SEBI Compliance Certificate for Depositories Regulation
Shree Ganesh Remedies Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE on April 08, 2026. Registrar Bigshare Services confirmed the regulation is not applicable as all company shares remain in demat form with no rematerialisation requests during the quarter. The filing demonstrates complete digital shareholding compliance for the period ended March 31, 2026.

*this image is generated using AI for illustrative purposes only.
Shree Ganesh Remedies Limited has filed its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The submission was made to BSE Limited on April 08, 2026, fulfilling regulatory requirements for listed companies.
Regulatory Compliance Details
The certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which pertains to the maintenance of securities in dematerialised form. Company Secretary Aditya Patel digitally signed and submitted the compliance document to the exchange.
| Parameter: | Details |
|---|---|
| Regulation: | SEBI (Depositories and Participants) Regulations, 2018 - Section 74(5) |
| Quarter Ended: | March 31, 2026 |
| Submission Date: | April 08, 2026 |
| Registrar: | Bigshare Services Private Limited |
| BSE Scrip Code: | 540737 |
Registrar Confirmation
Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate dated April 03, 2026. The registrar confirmed that Regulation 74(5) is not applicable to Shree Ganesh Remedies Limited due to specific compliance conditions being met.
According to the certificate signed by Akash Shamal, Authorized Signatory at Bigshare Services, the entire shareholding of the company remains in dematerialised form. The registrar reported receiving no requests from shareholders for either rematerialisation or dematerialisation during the quarter ended March 31, 2026.
Digital Shareholding Status
The compliance certificate highlights the company's complete transition to digital shareholding. With all shares maintained in demat form and no conversion requests during Q4FY26, Shree Ganesh Remedies demonstrates full adherence to modern securities holding practices.
The company operates from its head office located at Plot No. 6011, 6012, 6002 & 6003, GIDC Estate, Ankleshwar, Gujarat, and maintains ISO certifications for quality, environmental, and occupational health standards. The regulatory filing reflects the company's commitment to maintaining transparent compliance with SEBI regulations governing depositories and participant operations.
Historical Stock Returns for Shree Ganesh Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.73% | +8.91% | +9.30% | +6.75% | -27.05% | +119.63% |
How might Shree Ganesh Remedies' complete dematerialization status impact its liquidity and trading volumes in upcoming quarters?
What strategic initiatives could the company pursue given its strong regulatory compliance foundation and ISO certifications?
Will SEBI introduce additional regulatory requirements for depositories that could affect companies like Shree Ganesh Remedies in FY27?
































